Premium
Sernova Biotherapeutics Inc (PK) (SEOVF)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Ms. Tanya N. LewisIndependent Director & Observer | 426,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,56M | 37,63% |
| 2026-05-22 | Mr. David PatersonIndependent Director | 454,23k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,73M | 35,53% |
| 2026-05-22 | Dr. Stephen SanghaIndependent Director | 260,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,54M | 11,40% |
| 2026-05-22 | Dr. Bernd MuehlenwegIndependent Director | 433,42k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,74M | 33,30% |
| 2026-05-22 | Mr. John L. BrooksIndependent Chairman | 588,91k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,73M | 51,45% |
| 2026-04-16 | Dr. Stephen SanghaIndependent Director | 26,67M | 2,92M | Achat | 0,11 | 49,70M | 115,76% |
| 2026-04-14 | Dr. Stephen SanghaIndependent Director | 10,00M | 1,09M | Achat | 0,11 | 23,04M | 76,70% |
| 2026-04-14 | Mr. Jonathan M. N. RigbyPresident, CEO & Director | 229,88k | 31,74k | Achat | 0,14 | 229,88k | - |
| 2026-04-14 | Mr. James T. ParsonsCFO | 229,88k | 31,74k | Achat | 0,14 | 614,61k | 59,75% |
| 2026-03-03 | Mr. James T. ParsonsCFO | -100,00k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-03 | Dr. Stephen SanghaIndependent Director | -880,00k | 0,00 | Other Derivative Disposition | - | 16,00M | -5,21% |
| 2026-02-24 | Mr. John L. BrooksIndependent Chairman | 1,14M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,14M | - |
| 2026-02-24 | Mr. James T. ParsonsCFO | 2,25M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 7,32M | 44,38% |
| 2026-02-24 | Mr. Jonathan M. N. RigbyPresident, CEO & Director | 3,80M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 19,98M | 23,48% |
| 2026-02-24 | Dr. Bernd MuehlenwegIndependent Director | 337,47k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,30M | 35,00% |
| 2026-02-24 | Dr. Pericles CaliasChief Development Officer and Head of R&D | 600,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,60M | 60,00% |
| 2026-02-24 | Dr. Stephen SanghaIndependent Director | 880,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,28M | 62,85% |
| 2026-02-24 | Mr. David PatersonIndependent Director | 377,97k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,28M | 41,97% |
| 2026-02-24 | Ms. Tanya N. LewisIndependent Director & Observer | 323,97k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,13M | 40,03% |
| 2026-02-24 | Dr. Stephen SanghaIndependent Director | 269,98k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,40M | 23,89% |
| 2025-08-14 | Ms. Tanya N. LewisIndependent Director & Observer | 389,32k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 809,32k | 92,70% |
| 2025-08-14 | Dr. Bernd MuehlenwegIndependent Director | 404,19k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 964,19k | 72,18% |
| 2025-08-14 | Dr. Stephen SanghaIndependent Director | 420,26k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,13M | 59,19% |
| 2025-08-14 | Mr. David PatersonIndependent Director | 410,53k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 900,53k | 83,78% |
| 2025-08-01 | Mr. Jeffrey A. BachaInitié | -5,00k | 724,68 | Vente | 0,14 | 325,00k | -1,52% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
